The discount rate is supposed to reflect the risk free rate of return (i.e. what could you get as a return 'risk free' as an alternative). US Treasuries are often used or a companies WACC. And whilst many pundits increase the discount rate to reflect any increased risk (say looking at a small cap volatile cashflows vs a large cap or a large cap miner with mines in Africa vs mines in Australia, or looking at a clinical stage biotech vs a BP) KJT already provided for this risk by discounting the value (chance) of each cashflow separately rather than putting it in the discount rate.
So while he may have used a 8-12% as the 'discount rate' some of those cashflows were only given a % chance of occurring based on average approvals which effectively increases the discount rate (a 50% chance of getting approval applied equates to a doubling of the discount rate used, a 33% chance triples the discount rate applied, etc)
Not sure what discount rate was used by @Kjt1969 though?
- Forums
- ASX - By Stock
- NEU
- Pipeline-in-a-drug
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.80%
!
$12.54

Pipeline-in-a-drug, page-178
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1215 | $12.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.54 | 804 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 12.480 |
1 | 796 | 12.300 |
1 | 400 | 12.240 |
1 | 3000 | 12.230 |
1 | 761 | 12.210 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 1020 | 1 |
12.710 | 628 | 2 |
12.720 | 1982 | 1 |
12.820 | 3050 | 1 |
12.900 | 5012 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |